Brain Diseases: Clinical Trials

558 trials for Brain Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

558 unknown. 558 Phase 2, 100 Phase 1, 79 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 2558Unknown 558
Phase 1100Unknown 100
Phase 379Unknown 79

Follow Brain Diseases: new trials by email Literature Review of Brain Diseases trials Research Report on Brain Diseases

Trials (filtered) newest first · largest first

All 558 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tirofiban for the Prevention of Early Neurological Deterioration After Intravenous Thrombolysis in Acute Ischemic Stroke
Tirofiban Hydrochloride, Standard medical treatment (SMT) - Acute Stroke, Ischemic Stroke, Acute
Phase 2 / Phase 3UnknownCapital Medical University3022024-11-202024-10-29
Lateral Cord Magnetic Stimulation For Refractory Spastic Cerebral Palsy
Magnetic Spinal Stimulation - Spastic Cerebral Palsy, Dysarthria
Phase 2 / Phase 3UnknownSociedad Argenttina de Neuromodulación202024-11-182023-11-21
Cilostazol in Parkinson's Disease
Cilostazol, Placebo, Standard treatment - Parkinson's Disease
Phase 2UnknownAin Shams University502024-10-012024-09-25
Node-Sparing Short-Course Radiation With CAPOX and Sintilimab for MSS Locally Advanced Colon Cancer: A Randomized, Prospective, Multicenter Study
Node-Sparing Short-Course Radiotherapy Combined with CAPOX and Sintilimab, CAPOX Chemotherapy - Microsatellite Stable (MSS) Colon Cancer, Locally Advanced Colon Cancer
Phase 2UnknownSir Run Run Shaw Hospital1402024-10-012024-09-19
Cannabidiol's Role in Dementia Management
Cannabidiol Oil - Dementia, Vascular, Dementia, Mixed
Phase 2 / Phase 3UnknownHospital Pengajar Universiti Putra Malaysia4862024-09-012024-07-23
Emergency Stroke Unit for Acute Cerebrovascular Events ( ESU-ACE-B )
Emergency Stroke Unit based on 0.23-T MRI, Standard stroke unit adherent to guidelines - Ischemic Stroke, Acute
Phase 2UnknownYongjun Wang1002024-08-042024-08-12
The Safety and Efficacy of Rapamycin on Communicating Hydrocephalus Secondary to Intraventricular Hemorrhage
Rapamycin - Communicating Hydrocephalus, Cerebral Intraventricular Hemorrhage
Phase 2UnknownBeijing Tiantan Hospital532024-08-012024-08-21
Efficacy and Safety of Eliglustat in Chinese Pediatric Patients With Gaucher Disease Type 1 and Type 3
Eliglustat Tartrate Capsules - Gaucher Disease
Phase 2UnknownPeking Union Medical College Hospital52024-08-012024-07-26
Early Interferon-beta Treatment for West-Nile Virus Infection
Rebif 44 MCG Per 0.5 ML Prefilled Syringe, Saline - West Nile Virus, West Nile Fever Encephalitis
Phase 2UnknownTel-Aviv Sourasky Medical Center1002024-07-142024-07-23
European Blood Pressure Intensive Control After Stroke
anti-hypertensive, home blood pressure measurement, telemonitoring and medication titration, Standard of Care Blood Pressure Management with Antihypertensives - Ischemic Stroke, Transient Ischemic Attack
Phase 2UnknownUniversity College Dublin1422024-05-022024-07-11
Efficacy, Safety and Response Predictors of Astragalus Membranaceus on the Improvement of Cognitive Function in Mild-to-Moderate Alzheimer's Disease
10g Astragalus, Routine treatment, 20g Astragalus - Alzheimer's Disease
Phase 2UnknownFujian Medical University Union Hospital662024-05-012024-07-03
Nutritional Therapy in Late-onset Pompe Disease
Multi-ingredient supplement (PDT-MIS), Placebo (PLA) - Pompe Disease, Muscle Loss
Phase 2UnknownMcMaster University282024-04-012023-11-14
Evaluating the Effect of Tranexamic Acid on the Clinical Outcomes in Patients With Traumatic Brain Injury
Tranexamic Acid (TXA), Normal saline - Traumatic Brain Injury
Phase 1 / Phase 2UnknownMansoura University902024-03-252024-05-10
Cortical Excitability in West Syndrome Using Transcranial Magnetic Stimulation
ACTH/Oral Steroids - West Syndrome
Phase 2 / Phase 3UnknownAll India Institute of Medical Sciences402024-03-012024-03-04
Impact of Early Ventilation in Stroke Outcomes in Patients With Sleep Apnea After First Ever Stroke
Adaptive Servoventilation (ASV) therapy, Best medical treatment - Stroke, Sleep Apnea
Phase 2UnknownPhilips Portuguesa S.A.902024-02-272024-08-12
Efficacy, Safety and Response Predictors of Adjuvant Astragalus for Cognition in Orthostatic Hypotension
Routine treatment, add-on low dose Astragalus, add-on high dose Astragalus - Orthostatic Hypotension, Alzheimer Disease
Phase 2UnknownFujian Medical University Union Hospital662024-02-202024-01-05
BXOS110 Injection in the Treatment of Acute Ischaemic Stroke
high-dose BXOS110, low-dose BXOS110, Placebo - Acute Ischemic Stroke
Phase 2UnknownBiocells (Beijing) Biotech Co.,Ltd3002024-02-072024-03-21
SHR-A1921 Combined With Bevacizumab in Triple-negative Breast Cancer With Brain Metastases
SHR-A1921 + Bevacizumab - TNBC, Brain Metastasis
Phase 2UnknownFudan University242024-02-012024-01-18
Shuxuening Injection for the Prevention of CVS in Patients With aSAH(SXN-CVS)
Shuxuening injection or placebo - Subarachnoid Hemorrhage, Aneurysmal
Phase 2 / Phase 3UnknownXiaolin Chen, MD502024-01-242024-04-01
SGM-101 in Colorectal Brain Metastases.
SGM-101 - Rectal Neoplasms, Rectum Cancer
Phase 2UnknownLeiden University Medical Center102024-01-012024-05-09

Showing 20 of 558. Sign in to see all of them.

Narrower conditions

Brain Neoplasms (87)  ·  Stroke (82)  ·  Ischemic Stroke (68)  ·  Parkinson Disease (67)  ·  Alzheimer Disease (61)  ·  Brain Injuries, Traumatic (21)  ·  Carcinoma, Non-Small-Cell Lung (21)  ·  Cognitive Dysfunction (21)  ·  Cerebral Palsy (20)  ·  Migraine Disorders (18)  ·  Epilepsy (17)  ·  Glioblastoma (16)  ·  Cerebral Hemorrhage (15)  ·  Dementia (14)  ·  Breast Neoplasms (12)

Broader conditions

Central Nervous System Diseases (554)  ·  Nervous System Diseases (553)  ·  Cardiovascular Diseases (198)  ·  Vascular Diseases (196)  ·  Cerebrovascular Disorders (178)  ·  Neurodegenerative Diseases (145)  ·  Pathological Conditions, Signs and Symptoms (144)  ·  Mental Disorders (99)  ·  Neoplasms by Site (95)  ·  Neoplasms (94)  ·  Nervous System Neoplasms (92)  ·  Neurocognitive Disorders (91)  ·  Basal Ganglia Diseases (82)  ·  Central Nervous System Neoplasms (82)

Interventions

Sodium Chloride (13)  ·  Aspirin (12)  ·  Transcranial Direct Current Stimulation (10)  ·  Donepezil (8)  ·  Radiotherapy (8)  ·  Bevacizumab (7)  ·  Dexamethasone (7)  ·  Saline Solution (7)  ·  Temozolomide (7)  ·  Tissue Plasminogen Activator (7)  ·  Carboplatin (6)  ·  Erlotinib Hydrochloride (6)  ·  Atorvastatin (4)  ·  Botulinum Toxins, Type A (4)  ·  Diet, Ketogenic (4)

Sponsors

Beijing Tiantan Hospital (13)  ·  University of Calgary (12)  ·  Chang Gung Memorial Hospital (11)  ·  Capital Medical University (10)  ·  Fudan University (10)  ·  Tel-Aviv Sourasky Medical Center (8)  ·  National Taiwan University Hospital (7)  ·  Seoul National University Hospital (6)  ·  Hadassah Medical Organization (5)  ·  Samsung Medical Center (5)  ·  Sun Yat-sen University (5)  ·  Universidade Federal de Pernambuco (5)  ·  Xijing Hospital (5)  ·  Assistance Publique - Hôpitaux de Paris (4)  ·  Chaitanya Hospital, Pune (4)

Countries

China (130)  ·  United States (98)  ·  Canada (29)  ·  South Korea (27)  ·  France (25)  ·  Israel (24)  ·  Taiwan (21)  ·  Germany (18)  ·  Brazil (16)  ·  Netherlands (14)  ·  India (13)  ·  Italy (13)  ·  United Kingdom (13)  ·  Egypt (8)  ·  Iran (7)

Top investigators

Gang Zhao, M.D. (3)  ·  Sven Poli, Dr. med. (3)  ·  Abraham Lieberman, MD (2)  ·  Andrey S. Bryukhovetskiy, MD (2)  ·  Anthony Cardile, DO (2)  ·  Gene David Resnick, MD (2)  ·  Jeffrey Raizer, MD (2)  ·  John Fiveash, MD (2)  ·  Mark Reisman, MD (2)  ·  Robert J Schloesser, MD (2)  ·  Veronica Bruno, MD, MPH (2)  ·  Yilong Wang, PhD,MD (2)

Results publications

PMID 25303679, PMID 25789053, PMID 33175411, PMID 37870112, PMID 38648030, PMID 10655437, PMID 11105983, PMID 11231629, PMID 11399225, PMID 11452123, PMID 11937316, PMID 12177103, PMID 12434281, PMID 12465055, PMID 12529557, PMID 12750523, PMID 14506149, PMID 15037681, PMID 15496622, PMID 15714427, PMID 15809479, PMID 16011702, PMID 16078267, PMID 16108461, PMID 16214880, PMID 16265674, PMID 16282547, PMID 16336965, PMID 16510333, PMID 16574919, PMID 16598416, PMID 16645718, PMID 16757720, PMID 16877732, PMID 17229875, PMID 17509235, PMID 17544337, PMID 17647306, PMID 17909941, PMID 18211362, PMID 18217208, PMID 18289410, PMID 18442107, PMID 18468545, PMID 18546344, PMID 18577561, PMID 18591063, PMID 18990510, PMID 19061352, PMID 19074686

NIH funding

2019 (4), 2016 (3), 2018 (3), 2008 (2), 2014 (2), 2015 (2), 2005 (1), 2009 (1), 2017 (1), P30AG024978 (1), P30CA033572 (1), P30CA060553 (1), R01AG025502 (1), R01AG043398 (1), R01HD068712 (1)